Health Condition 1: M679- Unspecified disorder of synovium and tendon
Conditions
Interventions
Sponsors
Eligibility
Inclusion criteria
Inclusion criteria: 6 month history of shoulder pain Usg diagnostic of supraspinatus tendinopathy
Exclusion criteria
Exclusion criteria: Experiencing pain comorbid with adhesive capsulitis and limited ROM having received a steroid, PRP inj or any other injection in shoulder joint within 3 month H/o receiving joint replacement or arthroscopy surgery on the affected shoulder
Design outcomes
Primary
| Measure | Time frame |
|---|---|
| To compare the hypertonic dextrose prolotherapy and placebo in reducing pain and improving the ROM and functional capacity in patients with degenerative chronic supraspinatus tendinopathy in terms of VAS and SPADI scale.Timepoint: Outcome is assessed at baseline followed by follow up at 2 , 4 and 6 week after the intervention. | — |
Secondary
| Measure | Time frame |
|---|---|
| Any adverse effect occurs after the interventionTimepoint: Assessed at the time of intervention & after the intervention up to 6 week | — |
Countries
India
Contacts
SMS Medical College and Hospital